ABSTRACT: Tuberculosis (TB) primarily occurs in the foreign-born in European countries, such as the UK, where increasing notifications and the high proportion of foreign-born cases has refocused attention on immigrant (new entrant) screening. We investigated how UK primary care organisations (PCOs) screen new entrants and whether this differs according to TB burden in the PCOs (incidence ,20 or o20 cases per 100,000 per annum).
T uberculosis (TB) in Europe remains a public health concern. Although TB incidence has fallen in most European nations, there is increasing concern that these declines may not be sustained [1] . Whilst TB notifications among localborn nationals continue to fall, those from the foreign-born migrant population are worrying, as they continue to increase year on year [1] . As a result, foreign-born individuals, despite making up a minority of the general population in European countries, account for .40% of TB cases in several Western European nations, including Germany, France, Italy, Denmark, the Netherlands, Norway, Sweden and the UK [2] .
The UK epitomises the impact that migration from high TB burden nations has on TB epidemiology in low-burden European nations. TB notifications have increased by 40% between 1998 and 2008; over the same period, UK-born cases have fallen by 5%, whilst those amongst foreign-born individuals have increased by 94% [3] . Thus, foreignborn individuals now account for 72% of all cases, and have a TB incidence .20 times that of UKborn individuals (86 versus four cases per 100,000 per annum (p.a.), respectively) [3] . This epidemiology is driven by the synergy between migration from the Indian subcontinent and sub-Saharan Africa, which have the highest TB burdens in the world [4, 5] , and the reactivation of latent TB infection (LTBI) acquired in the countries of birth [6] soon after arrival in the UK. Consequently, ,50% of foreign-born cases occur in the first 5 yrs after migration (known as new entrants) [3] .
These contrasting data have refocused attention and debate on new entrant TB screening in Europe. Previous studies have found marked heterogeneity in the national guidelines followed by different European countries for TB screening AFFILIATIONS *Tuberculosis Research Unit, Dept of Respiratory Medicine, National Heart and Lung Institute, e MRC Centre for Outbreak Analysis and Modelling, UK policy advocates identification, chest radiography (CXR) and medical examination by port-of-entry Health Control Units for all new arrivals intending to stay for .6 months from countries with a TB incidence .40 cases per 100,000 p.a. (fig. 1 ) [9] . The results (called port forms) are forwarded, via local Health Protection Units, to local National Health Service (NHS) TB services covering the primary care organisation (PCO) area where the new entrant intends to settle to complete screening [9] . In 2006, the National Institute of Health and Clinical Excellence (NICE) issued new national guidelines for TB control and prevention with specific guidance on new entrant screening by local TB services [10] . In addition to screening for active TB, NICE recommends that local TB services should identify LTBI in a select subset of new entrants (all individuals ,16 yrs of age from countries with TB incidence .40 cases per 100,000 p.a. and 16-35-yr-olds from countries with TB incidence .500 cases per 100,000 p.a. or subSaharan Africa) [10] . NICE recommends step-wise diagnosis of LTBI beginning with a CXR that, if normal, is followed by a tuberculin skin test (TST) that, if positive, requires a confirmatory test with interferon-c release assays (IGRAs) prior to chemoprophylaxis [10] . These guidelines, the first in Europe to incorporate IGRAs into diagnostic algorithms for LTBI, were subsequently adopted by most high-income countries in Europe and North America [11, 12] .
Given that the UK exemplifies the enormous impact that migration from high TB burden nations has on the rapidly growing burden of TB among the foreign-born in low TB burden European nations, and has had guidelines for screening legal, documented new entrants in place for 4 yrs, it is an ideal European setting in which to undertake a nationwide study to evaluate the actual screening provision for legal, documented new entrants by local TB services, the level of adherence to national (NICE) guidance and how provision relates to the regional heterogeneity of the overall TB burden.
METHODS

Areas of interest in questionnaire
A 20-point anonymous questionnaire was developed (online supplementary information) to ask which groups of new entrants are routinely screened further (which port forms are acted on and whether new entrants identified through primary care registrations are screened), the numbers of new entrants screened and identified to have active TB or LTBI, which subgroups of new entrants are screened for LTBI, and the methods employed. The questionnaire was pre-piloted amongst TB nurses and public health specialists involved in new entrant screening. uncertainty, local Health Protection/Public Health Units in each PCO were also contacted to confirm to whom they forwarded the port forms. In most cases, local respiratory clinics/TB services undertook new entrant screening (usually TB clinical nurse specialists or respiratory physicians), although some areas delegated the task to specialist migrant nurses, health protection nurses or health visitors.
Sampling frame
Anonymous questionnaires were then e-mailed to those individuals who were most intimately involved in immigrant screening (usually in the local TB service), with a reminder e-mail and telephone call 4 weeks after the initial mailing. To take account of the fact that immigrant screening is complex and often undertaken in multiple locations, the investigator (M. Pareek) ensured that the most knowledgeable individual completed the questionnaire to encompass all possible avenues of screening immigrants. If the completed questionnaire was returned electronically, it was coded and the accompanying e-mail destroyed. In some cases, the questionnaires were completed over the phone with the investigator. At no point were any individual, person-specific data collected on the questionnaire.
Statistical analysis
PCOs were categorised as low or high TB burden (incidence ,20 or o20 TB cases per 100,000 p.a., respectively) according to their reported incidence in 2007 [13] [14] [15] [16] [17] [18] . Classification of port forms was consistent with national guidance (port form 103: CXR abnormal; port form 102: CXR inconclusive/has not been undertaken; port form 101: CXR normal). PCOs that screened port forms 102 and/or 101, or new entrants identified through primary care registrations, and offered chemoprophylaxis if appropriate, were defined as actively screening for LTBI. Adherence to NICE guidance on which new entrants should be screened for LTBI and the methods by which LTBI should be identified was defined as following the guidelines without deviation.
Categorical responses from low-and high-burden regions were compared using Pearson's Chi-squared test (or Fisher's exact test if appropriate) and unadjusted univariate odds ratios (with 95% confidence intervals). Continuous data were found to be non-normally distributed and, therefore, summarised as median and interquartile range (IQR), and compared using the nonparametric Mann-Whitney U-test. Missing data were excluded on a question-by-question basis. Analyses used STATA 9.2 (StataCorp, College Station, TX, USA). A p-value ,0.05 was considered significant.
RESULTS
Response rate and TB burden of responding PCOs
Responses were received from 177 (92.2%) out of 192 PCOs; 135 (76.3%) were categorised as low-TB burden areas. There was no significant difference between responders and nonresponders in terms of TB incidence (x 2 50.06; p50.79). Of the 65 (36.7%) out of 177 PCOs that provided details on the proportion of new entrants identified with active TB (there was no significant difference in those providing versus not providing yield data for active TB in terms of TB incidence (p51.0); see online supplementary information for numbers of active TB cases identified), the reported yield was very low with a median of 0.0% of new entrants (IQR 0.0-0.5%) eventually As a consequence, although a high proportion of PCOs adhered to NICE guidance on which ,16-and .35-yr-olds to screen for LTBI (91.6 and 94.3%, respectively), far fewer (49.5%) followed NICE guidance on which 16-35-yr-olds (who comprise the largest proportion of new entrants) to screen. There was no significant difference found between high-and low-burden PCOs with respect to adherence to this aspect of NICE guidance.
Selection of new entrants for further screening action
Methods of screening new entrants for LTBI and adherence to NICE guidance
Amongst the PCOs that screened for LTBI, the specific screening methods used are summarised in table 3. 
DISCUSSION
This nationwide evaluation of the provision of new entrant screening by local primary care organisations in the UK has revealed that although screening for active TB is consistently undertaken, screening for LTBI is highly variable, deviates from national guidance and is inversely related to regional TB burden. Our work suggests that heterogeneity particularly exists in the selection of new entrant subgroups to screen for LTBI and the specific methods used.
Migration and infectious diseases, particularly immigrant TB, are gaining increasing importance as a Europe-wide health policy issue [1] , suggesting that our findings have wider implications for most European nations. Our study methodology provides a basic template from which European nations can evaluate their own new entrant screening programmes to gain objective insights into how screening is undertaken at the front line, whether national guidance is being adhered to and whether screening relates to regional heterogeneity of TB burden within and across European Union member states.
We found that all PCOs screened new entrants issued with an abnormal CXR forms, presumably as they are suspected to have active TB and thus are perceived as the greatest threat to public health [9] . However, abnormal CXR forms comprise only a fraction of all port forms issued. More often, port forms indicate : data do not sum to total, as five low-and one high-burden PCO used more than one method of screening; " : data do not sum to total, as four PCOs in low-burden areas used more than one method of screening.
that the CXR is either inconclusive or has not been undertaken, or is normal, but our findings show that fewer PCOs (75.7 and 54.2%, respectively) attempt to undertake further screening action for these port notifications. Only 35% of PCOs reported routinely screening new entrants identified through primary care registrations. Therefore, the port-of-entry system remains the main method by which new entrants are identified and referred for further assessment by local TB services.
Few cases of active TB were diagnosed through new entrant screening (median 0.0%). Although only 65 out of 177 PCOs provided these data, the yields were similar to previous UK Health Protection Agency (HPA) estimates (0.12%) and local experience from port screening [19] [20] [21] . This reinforces the view that there is little pulmonary TB to identify amongst new entrants arriving in the UK, suggesting that the current emphasis on CXR for initial screening may be misplaced [22] . Indeed, a recent HPA review recommended urgently reassessing the benefits of continuing with the CXR as the initial diagnostic test for new entrants [19] .
Low yields of active TB and the fact that TB in the foreign-born results largely from reactivation of LTBI [6, 23] reinforce the potential of tackling LTBI in new entrants [10, 24, 25] . However, we found only 60.4% of PCOs screen new entrants for LTBI, despite the yield being higher than for active TB. Thus, a substantial proportion of UK PCOs are not implementing NICE guidance on LTBI screening [10] .
In addition, our study has revealed, for the first time, that highburden PCOs are significantly less likely to attempt to screen new entrants with normal CXRs for LTBI. This important finding suggests that high TB burden areas in the UK, which account for most foreign-born TB, are the most ethnically diverse (with individuals who have migrated from TBendemic regions, such as the Indian subcontinent and subSaharan Africa) [26, 27] and also have the highest prevalence of LTBI, are actually following up and screening the lowest proportion of new entrants. This potentially undermines national policy. Remedying this disparity between current practice and actual need requires a regionally targetted increase in resources.
Although it was beyond the scope of this study to identify reasons for the disparity in screening for LTBI, it is likely that PCOs determine which new entrants to screen based on pragmatic considerations, such as limited service capacity, a lack of dedicated funds for undertaking organised screening and a feeling that screening asymptomatic persons with normal CXRs provides little benefit in preventing TB [19, 28] . It is possible that auditing immigrant screening practices may reduce the heterogeneity that our study has uncovered.
Amongst PCOs that screen for LTBI, most were relatively consistent, and in line with NICE guidance, in which ,16-yrold (from countries with TB incidence .40 cases per 100,000 p.a.) and .35-yr-old (screening not recommended) new entrant subgroups they screened. However, most immigrants are 16-35 yrs of age and in this group, PCOs vary considerably in whom they screen for LTBI [4] . Whilst almost all PCOs screen individuals from countries with a TB incidence .500 per 100,000 p.a. and sub-Saharan Africa, in accordance with NICE, nearly half of PCOs still screened individuals from countries with a TB incidence .40 cases per 100,000 p.a. [10] . This heterogeneity probably reflects uncertainty about current NICE guidance, which has resulted in targetting only immigrants from sub-Saharan African countries, even though .60% of foreign-born cases occur in immigrants from non-subSaharan African regions, including the Indian Subcontinent, South-East Asia and Latin America, where TB incidence is 40-500 cases per 100,000 [3, 10, 29] .
In addition, PCOs used variable screening methods for adult new entrants. Although 72.2% of PCOs used IGRAs to identify LTBI, over a quarter still used the TST alone. Amongst PCOs that do employ IGRAs, most still used them to confirm a positive TST as per NICE guidance, though a few areas have now moved to single-step IGRA testing. This shift may have been driven by recent evidence suggesting IGRAs are cost-effective and, if positive, can predict progression to active TB [30, 31] .
Previous work in this area has been small scale, hampered by poor response rates, not focused on comparing screening practices by TB burden and, often, conducted prior to NICE guidance. Nonetheless, a prior smaller scale survey undertaken by the British Thoracic Society found that a low proportion of TB clinicians undertook new entrant screening [32] . A previous survey also found that less than half of public health consultants would act on port forms that indicate the CXR is either inconclusive or has not been undertaken, or is normal, with areas receiving most notifications actually screening the fewest new entrants [33] .
Our study has several limitations. The information was gathered through a questionnaire with the potential for recall/responder bias, especially for the small proportions that provided estimates of the yield for active and latent TB. In addition, this cross-sectional survey only provides a snapshot at one time-point. Although we focused on legal migrants, undocumented migrants are also a high-risk population who are likely to benefit from TB screening, although they are often difficult to identify.
Future work should consider emergent data highlighting the high prevalence of LTBI in new entrants and their elevated rate of progression to active TB [20, 30, 34, 35 ] to inform revised health economic models. The resultant cost-effectiveness analyses should, in turn, clarify the optimal threshold of TB incidence in immigrants' respective countries of origin at which to screen for LTBI and whether screening programmes should move from port-of-entry screening to a primary carebased model, which may facilitate wider migrant health programmes, such as blood-borne virus screening [20, 24, 36 ]. An urgent reappraisal of screening policy has recently been called for in the UK [37] , where the recently initiated review of NICE guidance provides a timely opportunity to prioritise screening for LTBI in a wider spectrum of new entrants to include those from the Indian subcontinent, especially in high-burden regions. 
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